RePer-AGE: Reorganization of Visuo-cognitive Functions Based on Peripheral Vision With Aging

NCT07727369 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-07-27

No results posted yet for this study

Summary

The RePer-AGE study investigates how central and peripheral vision contribute to visual recognition and how these mechanisms change with normal aging. The study is based on the hypothesis that peripheral vision provides rapid global information that supports visual recognition through predictive mechanisms. Healthy young adults (18-30 years) and older adults (60-85 years) will undergo visual psychophysical testing, ophthalmological examinations, and, for a subset of participants, functional magnetic resonance imaging (fMRI). The results are expected to improve our understanding of age-related changes in visuo-cognitive functions and provide reference data for future studies on age-related visual disorders.

Conditions

  • Aging
  • Visual Perception
  • Cognition

Interventions

BEHAVIORAL

Psychophysical visual recognition tasks

Computerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing.

DIAGNOSTIC_TEST

Ophthalmological assessment

Ophthalmological examinations including retinal sensitivity (Humphrey automated perimetry) and low-luminance visual acuity.

DIAGNOSTIC_TEST

Functional magnetic resonance imaging (fMRI)

Functional MRI performed during psychophysical visual recognition tasks to assess brain activity associated with visual recognition and predictive visual processing.

Sponsors & Collaborators

  • Centre National de la Recherche Scientifique, France

    collaborator OTHER
  • University Grenoble Alps

    collaborator OTHER
  • National Research Agency, France

    collaborator OTHER
  • University Hospital, Grenoble

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2030-03-31
Completion
2030-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07727369 on ClinicalTrials.gov